Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days £260.00 £353.00 Friday, 10th May 2024 HCM.L stock ended at £352.00. This is 13.55% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.22% from a day low at £342.00 to a day high of £353.00.
90 days £202.50 £353.00
52 weeks £173.60 £353.00

Historical Hutchison China Meditech Ltd ADR (Sponsored) prices

Date Open High Low Close Volume
Nov 09, 2023 £318.00 £318.00 £295.53 £301.00 105 802
Nov 08, 2023 £323.00 £323.00 £302.00 £318.50 112 125
Nov 07, 2023 £311.50 £324.95 £311.50 £322.00 245 411
Nov 06, 2023 £322.40 £325.55 £313.74 £321.00 248 236
Nov 03, 2023 £327.00 £331.00 £318.00 £321.00 163 105
Nov 02, 2023 £307.09 £323.00 £307.09 £320.00 181 045
Nov 01, 2023 £326.50 £326.50 £315.50 £320.00 250 150
Oct 31, 2023 £328.80 £330.39 £315.00 £319.00 179 554
Oct 30, 2023 £320.00 £338.00 £320.00 £326.00 398 632
Oct 27, 2023 £290.00 £309.00 £290.00 £303.00 283 266
Oct 26, 2023 £290.50 £290.50 £279.00 £281.00 68 483
Oct 25, 2023 £290.00 £294.00 £281.50 £282.50 158 352
Oct 24, 2023 £276.50 £288.00 £276.50 £285.50 278 179
Oct 23, 2023 £279.50 £279.50 £268.00 £270.00 64 649
Oct 20, 2023 £275.00 £285.00 £271.26 £276.00 173 461
Oct 19, 2023 £280.50 £287.50 £278.80 £282.00 12 396
Oct 18, 2023 £291.50 £291.50 £276.90 £278.00 74 671
Oct 17, 2023 £304.68 £304.68 £294.50 £299.50 122 991
Oct 16, 2023 £290.00 £306.96 £290.00 £305.00 207 969
Oct 13, 2023 £296.00 £298.14 £288.71 £294.00 311 920
Oct 12, 2023 £293.53 £293.53 £280.50 £285.00 246 990
Oct 11, 2023 £269.50 £290.00 £268.50 £283.50 163 982
Oct 10, 2023 £273.00 £273.00 £264.00 £268.00 8 470
Oct 09, 2023 £270.00 £289.50 £266.23 £274.00 32 488
Oct 06, 2023 £270.00 £273.00 £267.60 £271.00 25 606
Click to get the best stock tips daily for free!

About Hutchison China Meditech Ltd ADR (Sponsored)

Hutchison China Meditech Ltd ADR (Sponsored) HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for ... HCM.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT